heart failure
Becton Dickinson, Siemens Healthineers, Abbott Laboratories, Others Nab FDA Clearances in November
BioMérieux obtained FDA clearance for a multiplex RT-PCR assay that detects SARS-CoV-2 RNA in nasopharyngeal swabs from symptomatic individuals.
Ortho Clinical Diagnostics, Siemens Healthineers, Roche, and Others Obtain FDA Clearances in October
The FDA granted clearance to Roche for use of its Cobas Cdiff nucleic acid test, which detects the toxin B gene running on the firm's Liat point-of-care instrument.
The company, which received CE marking for its high sensitivity troponin I assay and Atellica VTLi Patient-side Immunoassay Analyzer, plans to enter the US market.
Quest Diagnostics, Zora Biosciences Sign Licensing Agreement for Cardiovascular Biomarkers
The company signed a non-exclusive license for Zora's ceramide markers and plans to launch a test based on the markers as early as next year.
Wyss Institute Developing Multiplex Electrochemical Testing Platform for Multiple Disease Conditions
The iQ Group Global is integrating the Wyss Institute's technology with its own organic thin-film biosensor platform for SARS-CoV-2 serology testing.Â